Policies & Perspectives

What Merck Believes
Clinical trial registries help patients and their healthcare providers learn about and gain access to relevant clinical trials of experimental treatments or preventative agents.

A clinical trial registry also serves those who analyze, report or publish the results of clinical trials by providing information on trials in progress and the ability to track such trials over the course of development.

In keeping with our publication guidelines, Merck is committed to disclosing balanced, complete and accurate information about our registered clinical trials of marketed products, regardless of outcome.

Learn more about our policies and perspectives:

• Clinical Trial Ethics
• Clinical Trial Registries and the Publication of Clinical Trial Results
• Merck Guidelines for Publication of Clinical Trials in the Scientific Literature
• Transparency Disclosures
• Access to Investigational Medicines

Clinical Trial Results
Merck and Schering-Plough clinical study results previously posted on the Pharmaceutical Research and Manufacturers of America (PhRMA) Clinical Study Results Database, as of December 2011 are available on www.merck.com and at the links below:

• PhRMA List for Legacy Merck Studies
• PhRMA List for Legacy SP/Organon Studies

Clinical Trial Data Sharing
Merck is committed to the PhRMA/EFPIA Principles for Responsible Clinical Trial Data Sharing.

Learn more about our policies and perspectives:

• Merck Procedure on Access to Clinical Trial Data
• Merck Procedure on CSR Synopsis Posting
• External Scientific Review Board (ESRB) Charter

Please click here to submit a research proposal.

To view our data sharing metrics for 2014-2023, click here.

RELATED INFORMATION

Becoming knowledgeable and informed is a first step when considering participation in a clinical trial. These additional resources for patients and caregivers may help you. 

Discover some of the resources available for patients and caregivers. 

---